Poseida Therapeutics Announces Nomination Of New CAR-T Development Candidate Under Collaboration with Roche, Triggering $15M Milestone Payment To Poseida
Portfolio Pulse from Benzinga Newsdesk
Poseida Therapeutics has announced a new CAR-T development candidate under its collaboration with Roche, which has triggered a $15 million milestone payment to Poseida.
October 17, 2024 | 12:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Poseida Therapeutics has nominated a new CAR-T development candidate in collaboration with Roche, resulting in a $15 million milestone payment to Poseida.
The announcement of a new CAR-T candidate and the associated $15 million milestone payment from Roche is a positive development for Poseida Therapeutics. This indicates progress in their collaboration and provides additional funding, which is likely to be viewed favorably by investors.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90